MDxHealth S.A.
MDXH
Peringkat dalam Saham
#21614
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Harga Saham
$3.39
Terakhir disinkronkan: 2023-12-15
Kapitalisasi Pasar
$96.16M
Perubahan (1 hari)
-1.73%
Perubahan (1 tahun)
-1.41%
Negara
BE
Perdagangan MDxHealth S.A. (MDXH)
Kategori
Healthcare
Riwayat harga saham MDxHealth S.A. (MDXH)
Harga penutupan tertinggi: $3.26 pada 2023-12-01
Harga penutupan terendah: $609.22 pada 2014-04-01
Harga penutupan terendah: $609.22 pada 2014-04-01
Riwayat harga saham MDxHealth S.A. dari 2014 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2023 | -94.81% |
| 2022 | -41.40% |
| 2021 | 0.43% |
| 2020 | -0.13% |
| 2019 | -49.53% |
| 2018 | -51.17% |
| 2017 | -13.55% |
| 2016 | 21.39% |
| 2015 | -23.63% |
| 2014 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $684.40 | 20.66% |
US
|
|
| $233.87 | 7.23% |
US
|
|
| $395.97 | 110.60% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.87 | 19.88% |
US
|
